Ellingson BM, Kim GHJ, Brown M, Lee J, et al. Volumetric measurements are preferred in the evaluation of mutant IDH inhibition in non-enhancing diffuse gliomas: Evidence from a phase I trial of Ivosidenib. Neuro Oncol 2021 Nov 9. pii: 6424025. doi: 10.1093.
PMID: 34751786